3
720 J ournal of Medicinal Chemistry, 2002, Vol. 45, No. 17
van der Stelt et al.
(
16) Baker, D.; Pryce, G.; Croxford, J . L.; Brown, P.; Pertwee, R. G.;
(36) Maccarrone, M.; Fiorucci, L.; Erba, F.; Bari, M.; Finazzi-Agro,
A.; Ascoli, F. Human mast cells take up and hydrolyze
anandamide under the control of 5-lipoxygenase and do not
express cannabinoid receptors. FEBS Lett. 2000, 468, 176-180.
(37) Ben-Shabat, S.; Fride, E.; Sheskin, T.; Tamiri, T.; Rhee, M. H.;
Vogel, Z.; Bisogno, T.; De Petrocellis, L.; Di Marzo, V.; Mechou-
lam, R. An entourage effect: inactive endogenous fatty acid
glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid
activity. Eur. J . Pharmacol. 1998, 353, 23-31.
Makriyannis, A.; Khanolkar, A.; Layward, L.; Fezza, F.; Bisogno,
T.; Di Marzo, V. Endocannabinoids control spasticity in
a
multiple sclerosis model. FASEB J . 2001, 15, 300-302.
(
17) Kunos, G.; J arai, Z.; Varga, K.; Liu, J .; Wang, L.; Wagner, J . A.
Cardiovascular effects of endocannabinoidssthe plot thickens.
Prostaglandins Other Lipid Mediators 2000, 61, 71-84.
(
18) van der Stelt, M.; Veldhuis, W.; van Haaften, G.; Fezza, F.;
Bisogno, T.; B a¨ r, P.; Veldink, G.; Vliegenthart, J .; DiMarzo, V.;
Nicolay, K. Exogenous anandamide protects rat brain against
acute neuronal injury in vivo. J . Neurosci. 2001, 21 (22), 8765-
(38) Rabinovich, A. L.; Ripatti, P. O. On the conformational, physical
properties and functions of polyunsaturated acyl chains. Bio-
chim. Biophys. Acta 1991, 1085, 53-62.
8
771.
(
19) Panikashvili, D.; Simeonidou, C.; Ben-Shabat, S.; Hanus, L.;
Breuer, A.; Mechoulam, R.; Shohami, E. An endogenous can-
nabinoid (2-AG) is neuroprotective after brain injury. Nature
(39) Rich, M. R. Conformational analysis of arachidonic and related
fatty acids using molecular dynamics simulations. Biochim.
Biophys. Acta 1993, 1178, 87-96.
2
001, 413, 527-531.
(40) Barnett-Norris, J .; Guarnieri, F.; Hurst, D. P.; Reggio, P. H.
Exploration of biologically relevant conformations of
anandamide, 2-arachidonylglycerol, and their analogues using
conformational memories. J . Med. Chem. 1998, 41, 4861-4872.
(41) Xie, X. Q.; Yang, D. P.; Melvin, L. S.; Makriyannis, A. Confor-
mational analysis of the prototype nonclassical cannabinoid CP-
47,497, using 2D NMR and computer molecular modeling. J .
Med. Chem. 1994, 37, 1418-1426.
(
20) Reggio, P. H.; Traore, H. Conformational requirements for
endocannabinoid interaction with the cannabinoid receptors, the
anandamide transporter and fatty acid amidohydrolase. Chem.
Phys. Lipids 2000, 108, 15-35.
(
(
(
21) Khanolkar, A. D.; Palmer, S. L.; Makriyannis, A. Molecular
probes for the cannabinoid receptors. Chem. Phys. Lipids 2000,
1
08, 37-52.
22) Porter, A. C.; Felder, C. C. The endocannabinoid nervous system.
Unique opportunities for therapeutic intervention. Pharmacol.
Ther. 2001, 90, 45-60.
(42) Reggio, P. H.; Greer, K. V.; Cox, S. M. The importance of the
orientation of the C9 substituent to cannabinoid activity. J . Med.
Chem. 1989, 32, 1630-1635.
(43) Sugiura, T.; Kodaka, T.; Nakane, S.; Miyashita, T.; Kondo, S.;
Suhara, Y.; Takayama, H.; Waku, K.; Seki, C.; Baba, N.; Ishima,
Y. Evidence that the cannabinoid CB1 receptor is a 2-arachi-
donoylglycerol receptor. Structure-activity relationship of
2-arachidonoylglycerol, ether-linked analogues, and related
compounds. J . Biol. Chem. 1999, 274, 2794-2801.
(44) van Zadelhoff, G.; Veldink, G. A.; Vliegenthart, J . F. With
anandamide as substrate plant 5-lipoxygenases behave like 11-
lipoxygenases. Biochem. Biophys. Res. Commun. 1998, 248, 33-
38.
(45) van der Stelt, M.; Nieuwenhuizen, W. F.; Veldink, G. A.;
Vliegenthart, J . F. Dioxygenation of N-linoleoyl amides by
soybean lipoxygenase-1. FEBS Lett. 1997, 411, 287-290.
(46) van der Stelt, M.; Paoletti, A. M.; Maccarrone, M.; Nieuwenhui-
zen, W. F.; Bagetta, G.; Veldink, G. A.; Finazzi Agr o` , A.;
Vliegenthart, J . F. G. The effect of hydroxylation of linoleoyl
amides on their cannabinomimetic properties. FEBS Lett. 1997,
415, 313-316.
(47) Ueda, N.; Yamamoto, K.; Kurahashi, Y.; Yamamoto, S.; Ogawa,
M.; Matsuki, N.; Kudo, I.; Shinkai, H.; Shirakawa, E.; Tokunaga,
T. Oxygenation of arachidonylethanolamide (anandamide) by
lipoxygenases. Adv. Prostaglandin Thromboxane Leukot. Res.
1995, 23, 163-165.
(48) Van Der Stelt, M.; Noordermeer, M. A.; Kiss, T.; Van Zadelhoff,
G.; Merghart, B.; Veldink, G. A.; Vliegenthart, J . F. G. Formation
of a new class of oxylipins from N-acyl(ethanol)amines by the
lipoxygenase pathway. Eur. J . Biochem. 2000, 267, 2000-2007.
(49) Devane, W. A.; Dysarz, F. A. d.; J ohnson, M. R.; Melvin, L. S.;
23) Thomas, B. F.; Adams, I. B.; Mascarella, S. W.; Martin, B. R.;
Razdan, R. K. Structure-activity analysis of anandamide ana-
logues: relationship to a cannabinoid pharmacophore. J . Med.
Chem. 1996, 39, 471-479.
24) Fichera, M.; Cruciani, G.; Bianchi, A.; Musumarra, G. A 3D-
QSAR study on the structural requirements for binding to CB-
(
(
2
1) and CB(2) cannabinoid receptors. J . Med. Chem. 2000, 43,
300-2309.
(
25) Tong, W.; Collantes, E. R.; Welsh, W. J .; Berglund, B. A.;
Howlett, A. C. Derivation of a pharmacophore model for
anandamide using constrained conformational searching and
comparative molecular field analysis. J . Med. Chem. 1998, 41,
4
207-4215.
(
26) Shim, J . Y.; Welsh, W. J .; Cartier, E.; Edwards, J . L.; Howlett,
A. C. Molecular interaction of the antagonist N-(piperidin-1-yl)-
5
3
-(4-chlorophenyl)-1- (2,4-dichlorophenyl)-4-methyl-1H-pyrazole-
-carboxamide with the CB1 cannabinoid receptor. J . Med.
Chem. 2002, 45, 1447-1459.
(
27) Edgemond, W. S.; Hillard, C. J .; Falck, J . R.; Kearn, C. S.;
Campbell, W. B. Human platelets and polymorphonuclear
leukocytes synthesize oxygenated derivatives of arachidonyl-
ethanolamide (anandamide): their affinities for cannabinoid
receptors and pathways of inactivation. Mol. Pharmacol. 1998,
5
4, 180-188.
(
28) Hampson, A. J .; Hill, W. A.; Zan-Phillips, M.; Makriyannis, A.;
Leung, E.; Eglen, R. M.; Bornheim, L. M. Anandamide hydroxy-
lation by brain lipoxygenase: metabolite structures and poten-
cies at the cannabinoid receptor. Biochim. Biophys. Acta 1995,
1
259, 173-179.
Howlett, A. C. Determination and characterization of a
cannabinoid receptor in rat brain. Mol. Pharmacol. 1988, 34,
605-613.
(
(
(
(
29) Sheskin, T.; Hanus, L.; Slager, J .; Vogel, Z.; Mechoulam, R.
Structural requirements for binding of anandamide-type com-
pounds to the brain cannabinoid receptor. J . Med. Chem. 1997,
(50) Bradford, M. M. A rapid and sensitive method for the quanti-
tation of microgram quantities of protein utilizing the principle
of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
(51) Compton, D. R.; Rice, K. C.; De Costa, B. R.; Razdan, R. K.;
Melvin, L. S.; J ohnson, M. R.; Martin, B. R. Cannabinoid
structure-activity relationships: correlation of receptor binding
and in vivo activities. J . Pharmacol. Exp. Ther. 1993, 265, 218-
226.
4
0, 659-667.
30) Piomelli, D.; Beltramo, M.; Glasnapp, S.; Lin, S. Y.; Goutopoulos,
A.; Xie, X. Q.; Makriyannis, A. Structural determinants for
recognition and translocation by the anandamide transporter.
Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 5802-5807.
31) Hillard, C. J .; Edgemond, W. S.; J arrahian, A.; Campbell, W. B.
Accumulation of N-arachidonoylethanolamine (anandamide) into
cerebellar granule cells occurs via facilitated diffusion. J . Neu-
rochem. 1997, 69, 631-638.
32) Boger, D. L.; Sato, H.; Lerner, A. E.; Hedrick, M. P.; Fecik, R.
A.; Miyauchi, H.; Wilkie, G. D.; Austin, B. J .; Patricelli, M. P.;
Cravatt, B. F. Exceptionally potent inhibitors of fatty acid amide
hydrolase: the enzyme responsible for degradation of endog-
enous oleamide and anandamide. Proc. Natl. Acad. Sci. U.S.A.
(52) Maccarrone, M.; Bari, M.; Lorenzon, T.; Bisogno, T.; Di Marzo,
V.; Finazzi-Agro, A. Anandamide uptake by human endothelial
cells and its regulation by nitric oxide. J . Biol. Chem. 2000, 275,
13484-13492.
(53) van Gunsteren, W. F.; Berendsen, H. J . C. GROMOS-87:
Groningen Molecular Simulation Program Package; Groningen,
The Netherlands, 1987.
(54) Berendsen, H. J . C.; Grigera, J . R.; Straatsma, T. P. The missing
term in effective pair potentials. J . Phys. Chem. 1987, 91, 6269-
6271.
(55) Rykaert, J . P.; Giccotti, G.; Berendsen, H. J . C. Numerical
integration of the Cartesian equation of motion of a system with
constraints: molecular dynamics of N-alkanes. J . Comput. Phys.
1987, 23, 327-341.
(56) Berendsen, H. J . C.; Postma, J . P. M.; van Gunsteren, W. F.; Di
Niola, A.; Haak, J . R. Molecular dynamics with coupling to an
external bath. J . Chem. Phys. 1984, 81, 3684-3690.
2
000, 97, 5044-5049.
(
33) Stella, N.; Schweitzer, P.; Piomelli, D. A second endogenous
cannabinoid that modulates long-term potentiation. Nature
1
997, 388, 773-778.
(
34) Ueda, N.; Yamamoto, K.; Yamamoto, S.; Tokunaga, T.; Shira-
kawa, E.; Shinkai, H.; Ogawa, M.; Sato, T.; Kudo, I.; Inoue, K.;
et al. Lipoxygenase-catalyzed oxygenation of arachidonyletha-
nolamide, a cannabinoid receptor agonist. Biochim. Biophys.
Acta 1995, 1254, 127-134.
(
35) Moody, J . S.; Kozak, K. R.; J i, C.; Marnett, L. J . Selective
oxygenation of the endocannabinoid 2-arachidonylglycerol by
leukocyte-type 12-lipoxygenase. Biochemistry 2001, 40, 861-866.
J M020818Q